SCHEMBL27770357

SCHEMBL27770357

O=CC1NN=C(Br)N1Cc1ccccc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.37
ALDH1A1 P00352 9/20 0.37
MAPT P10636 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C19 P33261 2/20 0.37
KDM4E B2RXH2 2/20 0.37
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
HTT P42858 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
GRM2 Q14416 1/20 0.36
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
PKM P14618 3/20 0.34
LMNA P02545 1/20 0.34
THRB P10828 1/20 0.34
PKLR P30613 1/20 0.34
TSHR P16473 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27749333 0.76 GRM2 (0.41) L3MBTL1ALDH1A1SMN1; SMN2GRM2KMT2A
SCHEMBL27749332 0.75 AVPR2 (0.36) L3MBTL1ALDH1A1MAPTCYP1A2CYP2C19
SCHEMBL27770355 0.67
SCHEMBL28305131 0.63 EHMT2 (0.42) ALDH1A1KDM4EPOLBSMN1; SMN2KMT2A
SCHEMBL27949939 0.62 P2RX7 (0.45) ALDH1A1KDM4EKMT2AMEN1LMNA
SCHEMBL28552309 0.61 ATM (0.58) ALDH1A1KDM4EPOLBHTTKMT2A
SCHEMBL21847081 0.61 L3MBTL1 (0.45) L3MBTL1ALDH1A1MAPTCYP1A2CYP2C19
SCHEMBL27473060 0.60
SCHEMBL3982942 0.60 ALDH1A1 (0.52) L3MBTL1ALDH1A1MAPTCYP1A2CYP2C19
SCHEMBL3605369 0.58 GRM2 (0.49) L3MBTL1ALDH1A1MAPTCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101495458-A Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors BAYER HEALTHCARE AG (DE) 2009-07-29 CN disclosed